A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...

Novartis has operated in North Carolina for more than two decades, delivering gene therapies and other lifesaving treatments ...

Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been ...

New legislation proposed by a bipartisan and bicameral group of Congressional legislators and supported by the North Carolina ...

Precise Bio Inc., a Greensboro-based clinical-stage regenerative medicine company, has announced the world’s first transplant ...

Join AgBio+AgTech at the First Flight Venture Center for a conversation with Dr. Sharon Inch, plant pathologist and innovator behind Soil Sync and AgVision Analytics. Dr. Inch will share how she ...

Join Innovate Carolina on December 4 for an evening celebrating innovation, invention, and the journey from academic discovery to real-world impact.

Innatrix‘s lead product, InnaNema, targets soybean cyst nematode, one of the most damaging pests for U.S. soybean crops.

Novartis Gene Therapies, a division of Switzerland-based Novartis, one of the world’s largest pharmaceutical companies, plans to expand in the Research Triangle with $771 million of investments at ...

Networking. Training events. Employment opportunities. NCBiotech can connect you with the next job or company you need to advance your career in life sciences. NCBiotech connects you to resources for ...